Home › Research › Zhou BSTc
Zhou Brain Research (1995): The Myth of the "Trans-Brain"
"Studies show that trans women have female brains" — a creed that is repeated everywhere. The source is almost always a single study: Zhou (1995) on the BSTc brain nucleus. Six brains, hormone-confounded, never properly replicated — yet sold as "scientific proof" for thirty years.
What Zhou did
Zhou et al. (1995) examined six post-mortem brains of male transsexuals, nine male controls, and six female controls. They measured the volume of the bed nucleus of the stria terminalis, central subdivision (BSTc). Result: the BSTc volume of the transsexuals was closer to that of women than that of men. The detail that was quickly overlooked: all six subjects had been taking estrogen for years.
Problem 1 — all subjects on cross-hormones
The six transsexual subjects all received estrogen for years. Adult hormone exposure demonstrably affects brain structure; in animal studies, BSTc volume is hormone-sensitive. The study therefore does not measure "being trans" — it measures the effect of hormones. A second-year methodology student would already cross out the conclusion. Yet it is cited in arguments for the transition of minors.
Problem 2 — own follow-up research undermines the premise
Chung et al. (2002) — the same group — showed that the sexual dimorphism in BSTc only develops in adulthood, not prenatally as Zhou suggested. This eliminates the passage of time: an "innate" brain feature cannot possibly explain why a child feels "in the wrong body" at age eight. It undermines the entire innate-essence claim.
Problem 3 — minuscule sample, post-mortem, no replication
Six subjects is a disaster for neuroanatomical claims. Post-mortem comparisons are particularly susceptible to confounders: age, cause of death, medical history, duration of fixation, AIDS status (relevant in the 1990s sample). The study has never been thoroughly replicated. Yet it is cited time and again as if "the evidence is there" — a classic example of publication bias and myth-making .
Problem 4 — no biomarker, nowhere
There is no reproducible brain marker by which "being trans" can be identified. No MRI, no DTI, no volumetry. The Cass Review (2024) explicitly concludes that there is no biological marker for gender identity. See also no brain marker and no measurable marker . A social pattern such as ROGD —peer cluster, internet, social contagion—would by definition have no brain marker. Finding nothing is the expected result here.
What this means
The claim "trans-brains exist" rests on weak data from thirty years ago, not replicated, with fatal methodological problems. Whoever repeats it relies on authority and peer pressure, not on evidence. It fits into a broader pattern: an unfalsifiable metaphysical claim packaged as science, used to justify puberty blockers and mastectomies in healthy minors.
Some studies (Luders, Burke) report tentative differences, but results are small, inconsistent, non-replicable, and possibly hormone-dependent. No consensus, no clinically useful marker. See no brain marker .
Cass (2024) explicitly states that there is no conclusive neurobiological marker for gender dysphoria or transidentity. With this, the "trans-brain" rhetoric loses all medical foundation.
Because the outcome is politically desirable and criticism is silenced. Anyone who points out the shortcomings is dismissed as transphobic — a typical reaction to criticism regarding an ideologically charged subject.
Sources
- Zhou, J. N. et al. (1995). A sex difference in the human brain and its relation to transsexuality. Nature .
- Chung, WCJ et al. (2002). Sexual differentiation of the bed nucleus of the stria terminalis. J. Neuroscience . jneurosci.org
- Hruz, P. et al. (2017). Growing pains: problems with puberty suppression. The New Atlantis .